An observational study in Healthy Volunteer, Dermatologic Diseases and Systemic Diseases, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Completed at 1 site in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Observational
Background:
-This protocol is concerned with the acquisition of blood, skin, or mucosal samples from healthy volunteers or patients with selected skin diseases to support the basic science and clinical research activities of the Dermatology Branch and other intramural Laboratories and Branches at the NIH Clinical Research Center.
Objectives:
(Primary)
-To allow collection of blood, skin, or mucosal samples from healthy volunteers or patients with selected skin or systemic diseases as needed to support the research activities of our Branch and other Laboratories and Branches.
Eligibility:
Design:
-This is dependent upon the particular investigation for which these samples are needed.
Background:
-This protocol is concerned with the acquisition of blood, skin, or mucosal samples from healthy volunteers or patients with selected skin diseases to support the basic science and clinical research activities of the Dermatology Branch and other intramural Laboratories and Branches at the NIH Clinical Research Center.
Objectives:
(Primary)
-To allow collection of blood, skin, or mucosal samples from healthy volunteers or patients with selected skin or systemic diseases as needed to support the research activities of our Branch and other Laboratories and Branches.
Eligibility:
Design:
-This is dependent upon the particular investigation for which these samples are needed.
496 studies on the registry are indexed under Skin Diseases; 77 are open to participants now.
This study's enrollment of 304 is above the median of 165 across 101 observational studies indexed under Skin Diseases.
Browse Skin Diseases studies →National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is the lead sponsor of 100 studies on the registry; 12 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 5 (71%) have results posted.
Counted across the registry records on this site, refreshed daily.
Healthy volunteers or patients with selected skin diseases
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Healthy individuals (including employees and other patients), and patients with selected skin or other diseases, including individuals of both genders and all racial/ethnic groups.
Patient volunteers must be willing to undergo blood drawing and/or skin/mucosal sampling/monitoring to include non-invasive skin samples.
EXCLUSION CRITERIA:
Strong family history and/or evidence of keloid formation following surgery or trauma.
Children under the age of 18 years.
Pregnant women
Healthy individuals (including employees and other patients) and patients with selected skin or other diseases
Collection of blood, skin, or mucosal samples from healthy volunteers or patients with selected skin or systemic diseases
Collection of blood, skin, or mucosal samples from healthy volunteers or patients with selected skin or systemic diseases
Time frame: Ongoing
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) →